| 2026-07-29 | Press release | Adaptive Biotechnologies Reports Second Quarter 2026 Financial Results |
| 2026-07-09 | Press release | Adaptive Biotechnologies to Report Second Quarter 2026 Financial Results on July 29, 2026 |
| 2026-06-17 | Press release | Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering |
| 2026-06-15 | Press release | Adaptive Biotechnologies Corporation Announces Proposed Convertible Senior Notes Offering |
| 2026-06-15 | Press release | Adaptive Biotechnologies Announces Plan to Separate Its MRD and Immune Medicine Businesses |
| 2026-05-29 | Press release | At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice a |
| 2026-05-21 | Press release | Adaptive Biotechnologies to Participate in Upcoming Investor Conferences |
| 2026-02-05 | Earnings deck | Adaptive Biotechnologies Q4 and FY 2025 Earnings Presentation |
| 2026-02-05 | Press release | Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results |
| 2025-12-30 | Press release | Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference |
| 2025-12-06 | Press release | Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Inter |
| 2025-02-11 | Earnings deck | Adaptive Biotechnologies Q4 and FY 2024 Earnings Presentation |
| 2025-02-11 | Press release | Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results |
| 2025-01-22 | Press release | Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025 |
| 2025-01-14 | Presentation | View Presentation |
| 2025-01-07 | Press release | Adaptive Biotechnologies Announces Clinical Lab Fee Schedule Rate of $2,007 for clonoSEQ® Test for Minimal Residual Dise |
| 2024-11-07 | Earnings deck | Adaptive Biotechnologies Q3 2024 Earnings Presentation |
| 2024-11-07 | Press release | Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results |
| 2024-10-09 | Press release | Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024 |
| 2024-08-29 | Press release | Adaptive Announces IVDR Certification for clonoSEQ® in European Union |
| 2024-08-01 | Earnings deck | Adaptive Biotechnologies Q2 2024 Earnings Presentation |
| 2024-08-01 | Press release | Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results |
| 2024-07-11 | Press release | Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024 |
| 2024-05-07 | Earnings deck | Adaptive Biotechnologies Q1 2024 Earnings Presentation |
| 2024-05-07 | Press release | Adaptive Biotechnologies Reports First Quarter 2024 Financial Results |
| 2024-02-14 | Earnings deck | Adaptive Biotechnologies Q4 2023 Earnings Presentation |
| 2024-02-14 | Press release | Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results |
| 2024-01-29 | Press release | Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024 |
| 2023-11-09 | Earnings deck | Adaptive Biotechnologies Q3 2023 Earnings Presentation |
| 2023-11-09 | Press release | Adaptive Biotechnologies Reports Third Quarter 2023 Financial Results and Provides Business Update |
| 2023-11-02 | Press release | Adaptive Biotechnologies to Report Third Quarter Financial Results on November 9, 2023 |
| 2023-08-02 | Earnings deck | Adaptive Biotechnologies Q2 2023 Earnings Presentation |
| 2023-08-02 | Press release | Adaptive Biotechnologies Reports Second Quarter 2023 Financial Results |
| 2023-07-10 | Press release | Adaptive Biotechnologies to Report Second Quarter Financial Results on August 2, 2023 |
| 2023-05-12 | Press release | Adaptive Biotechnologies to Participate in the 2023 RBC Capital Markets Global Healthcare Conference |
| 2023-05-03 | Earnings deck | Adaptive Biotechnologies Q1 2023 Earnings Presentation |
| 2023-05-03 | Press release | Adaptive Biotechnologies Reports First Quarter 2023 Financial Results |
| 2023-04-25 | Press release | Adaptive Biotechnologies to Participate in the BofA Securities 2023 Healthcare Conference |
| 2023-04-06 | Press release | Adaptive Biotechnologies to Report First Quarter Financial Results on May 3, 2023 |
| 2023-02-27 | Press release | Adaptive Biotechnologies to Participate in the 43rd Annual Cowen Healthcare Conference |